Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Protein Digestion01:02

Protein Digestion

Protein digestion begins in the stomach, where the highly acidic environment can easily disrupt protein structure by exposing the peptide bonds of polypeptide chains. After polypeptide chains are broken into individual amino acids by a series of digestive enzymes, the amino acids are transported to the liver via the bloodstream to produce energy.
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification and initial characterisation of Trypanosoma Cox17 copper metallochaperone.

Molecular and biochemical parasitology·2025
Same author

Expression and copper binding studies of a Plasmodium falciparum protein with Cox19 copper binding motifs.

Experimental parasitology·2023
Same author

A single exon-encoded Theileria parva strain Muguga cysteine protease (ThpCP): Molecular modelling and characterisation.

Biochimie·2022
Same author

Expression and copper binding characteristics of Plasmodium falciparum cytochrome c oxidase assembly factor 11, Cox11.

Malaria journal·2022
Same author

Low Dose Gamma Irradiation of <i>Trypanosoma evansi</i> Parasites Identifies Molecular Changes That Occur to Repair Radiation Damage and Gene Transcripts That May Be Involved in Establishing Disease in Mice Post-Irradiation.

Frontiers in immunology·2022
Same author

Homology modelling of Trypanosoma brucei major surface proteases and molecular docking of variant surface glycoproteins and inhibitor ligands for drug design.

Journal of molecular graphics & modelling·2021

Related Experiment Video

Updated: Jul 10, 2026

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
11:27

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050

Published on: May 13, 2020

Oligopeptidase B: a processing peptidase involved in pathogenesis.

Theresa H T Coetzer1, J P Dean Goldring, Laura E J Huson

  • 1Biochemistry, School of Biochemistry, Genetics, Microbiology and Plant Pathology, University of KwaZulu-Natal (Pietermaritzburg campus), Private bag X01, Scottsville 3201, South Africa. coetzer@ukzn.ac.za

Biochimie
|November 22, 2007
PubMed
Summary

Oligopeptidase B, a bacterial serine peptidase, uniquely cleaves peptides at basic amino acids. Its structure, function, and role in trypanosomosis highlight its potential as a drug target.

More Related Videos

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
13:34

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD

Published on: December 30, 2016

Related Experiment Videos

Last Updated: Jul 10, 2026

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
11:27

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050

Published on: May 13, 2020

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
13:34

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD

Published on: December 30, 2016

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Oligopeptidase B (OB) is a serine peptidase from the prolyl oligopeptidase family found in bacteria, protozoa, and plants.
  • Unlike other prolyl oligopeptidases, OB cleaves peptides at the carboxyl side of basic amino acid residues.

Purpose of the Study:

  • To review the structure-function properties of Oligopeptidase B.
  • To explore its physiological and pathological roles.
  • To assess its potential as a drug target.

Main Methods:

  • Molecular modeling and mutation studies to identify key residues in substrate and inhibitor binding.
  • Analysis of inhibition by various small molecule inhibitors and resistance to proteinaceous inhibitors.
  • Structural analysis of domain interactions influencing substrate access.

Main Results:

  • Carboxyl dyads in the C-terminal catalytic domain mediate substrate and inhibitor binding.
  • OB is efficiently inhibited by specific non-peptide inhibitors but not by large protein inhibitors.
  • The N-terminal beta-propeller domain restricts access for large substrates and inhibitors.

Conclusions:

  • Oligopeptidase B's unique catalytic activity and structural features present distinct biochemical properties.
  • Despite its unelucidated physiological role, OB is a significant virulence factor in animal trypanosomosis.
  • Its characteristics position Oligopeptidase B as a promising therapeutic target for drug development.